Dynamic Response Group to start national media campaign for its diabetic supply products to the Hispanic market

Dynamic Response Group, Inc. (OTCBB: DRGZ) announced today on October 19, 2009 it will start the national media campaign to roll-out its Medico Express diabetic supply products to the Hispanic market. The Company will begin airing television infomercials on Univision, Telefutura and Telemundo the three most watched Hispanic speaking stations. As the only company nationally addressing this niche, Dynamic Response Group (DRG) projects revenues from Medico to reach $13 million in 2010 more than tripling to $40 million by 2011.

"The national roll-out of Medico Express, DRG's diabetic product supply subsidiary and most recent venture into the Home Medical Equipment (HME) market, marks a tremendous growth opportunity for our Company," noted Melissa K. Rice, CEO. "The Hispanic population is the second-largest and fastest growing minority group in the United States and is now experiencing a dramatic increase in the incidence of diabetes. DRG's proven experience in the direct television industry has already created enormous income opportunities for our Company in this market."

The Hispanic market for diabetic products is estimated to be $748 million in the continental U.S. and is expected to surpass $1 billion in the next few years according to the Center for Disease Control. DRG's Medico Express offers the core products that are used regularly by diabetics. Studies show that Hispanics are almost twice as likely to develop diabetes as Caucasians of similar age which supports the fact that the Company's actual market test results far exceeded management's initial expectations.

Source:

Dynamic Response Group, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tirzepatide cuts diabetes risk by 90% in obese patients, study shows